SEC Form 4 · accession 0001181431-15-005747
Sagent Pharmaceuticals, Inc. · SGNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Kung
Director
Period of report
Apr 9, 2015
Accepted (ET)
Apr 13, 2015 · 11:34 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369786
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Apr 9, 2015 | A | 921 | A | — | — | Common Stock | 921 | 921 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of SGNT common stock. The reported restricted stock units were intended to be granted to the reporting person on February 25, 2015 and were mistakenly omitted from the grant due to administrative error.
- F2The restricted stock units vest in four equal annual installments beginning on February 25, 2016. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date.